NPC is characterized by high programmed death-ligand 1 (PD-L1) expression and abundant tumor-infiltrating lymphocytes, providing a strong biological rationale for incorporating immunotherapy in the treatment of this disease [5–7]. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.